SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's after-hours surge is fueled by better-than-expected earnings and strong Q4 guidance, particularly driven by AWS growth. Community discussions revolve around potential ATH and target prices, with many regretting not buying more, while some caution against greed and anticipate a pullback. The earnings beat, especially in cloud services, has reignited bullish sentiment around the stock.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's earnings are driving significant after-hours discussion, with the community dissecting revenue and future guidance, particularly strong expectations for the December quarter due to iPhone 17 demand. Despite mixed reactions to specific figures like China revenue, the overall sentiment leans bullish, with some eyeing price targets and anticipating upgrades. Community members are actively debating whether the current valuation is justified and if profit-taking is imminent.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy ($MSTR) is trending following its Q3 earnings report, with community chatter focused on the company's significant earnings beat driven by its Bitcoin holdings. Despite the positive results, some investors express concern over the stock's price movement and the broader context of its business model, while others point to potential S&P 500 inclusion and analyst upgrades as bullish signals.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit's stock is trending as investors digest the company's earnings report and future outlook, with strong reactions and debate within the community. Discussion centers on growth metrics, AI licensing deals, and advertising revenue as key factors influencing the stock's potential. Some traders are anticipating analyst upgrades while others express concerns about competition and valuation.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending following an analyst upgrade from JP Morgan, with the community noting its outperformance relative to Bitcoin YTD. Bullish sentiment is building ahead of earnings, as investors anticipate a potential breakout driven by increased crypto activity and key partnerships. Some traders are closely watching technical levels, while others express caution based on past earnings reactions.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid speculation of a potential acquisition, with Netflix and Comcast reportedly expressing interest. Community members are actively discussing potential bidding wars and the likelihood of a deal being finalized. The focus remains on whether a buyout will occur and at what price, considering the company's debt and the value of its content.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

GSAT is trending amid speculation of a potential sale, with SpaceX named as a possible suitor, sparking community discussion around potential buyout prices and the involvement of key partners like Apple. Investors are also weighing the significance of Globalstar's n53 spectrum and potential deals with Amazon and Walmart. Some traders are expressing hope for a short squeeze.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

RKT is trending as investors discuss the potential for a short squeeze following strong earnings and positive Q4 revenue guidance. Community members are highlighting the high short interest and upcoming catalysts like potential rate cuts and the integration of recent acquisitions. Some are closely watching for analyst upgrades and increased price projections amidst discussions of long-term growth potential in the housing market.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following a commercial momentum update for IBSRELA/XPHOZAH and discussion of upcoming pediatric/expansion catalysts. Community members are discussing the company's undervaluation, comparing its financials to similar companies, and highlighting management's confidence. Bullish sentiment is fueled by positive earnings reports and anticipation of upgrades, with some focusing on the potential of their pipeline program.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending following news of new PCF deals and a recent partnership with PLTR, sparking excitement about the company's potential in AI infrastructure. The community is buzzing over the transition from telecom to AI/fiber optics and the potential for significant growth, with some anticipating analyst upgrades and future partnerships. Discussions also focus on revenue, debt, and the impact of Project Berkeley on Lumen's market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of InMed Pharmaceuticals surged to levels not seen in nearly five months, capturing significant attention from retail investors.&nbsp;The biopharma company, with a market cap of just under $4 million, announced on Tuesday that its INM-901 small molecule drug candidate for Alzheimer's disease demonstrated promising results in a recent clinical trial.The study showed that INM-901 significantly reduced several markers of neuroinflammation, both in plasma and the brain.&nbsp;Specifically, the high-dose treated group exhibited a dose-dependent reduction in pro-inflammatory cytokines and neurofilament light chain levels in the plasma.&nbsp;Additionally, the trial indicated a reduction in key neuroinflammatory genes in the brain, signaling a potential breakthrough in Alzheimer's treatment.Eric Hsu, InMed's Senior Vice President of Preclinical R&amp;D, expressed excitement over the results, noting, "The ability of INM-901 to actively reduce inflammation is an exciting development, as neuroinflammation has emerged as a promising new drug target beyond existing AD treatments focused primarily on removing amyloid beta plaques and tau protein tangles."&nbsp;He added, "INM-901 may address multiple pathological factors, making it a very promising drug candidate."The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.&nbsp;One user expressed happiness with the stock's surge and speculated on the potential for a buy-out.<stembedurl>https://stocktwits.com/pennyman/message/600871159</stembedurl>Another suggested that InMed's current levels were too good an entry point to miss.<stembedurl>https://stocktwits.com/AmbushPredator/message/600878277</stembedurl>According to Koyfin data, InMed has only about 718,000 shares outstanding and a short interest of 1.3%.&nbsp;While <a href="https://stocktwits.com/symbol/INM">InMed's stock</a> is down nearly 30% over the past 12 months, it has gained approximately 14% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise

The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform. 

Equity

The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform. 


EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says

InMed Pharmaceuticals is making strides in Alzheimer's research with its development of a cannabinoid-based compound.
read more...

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies

INM-901 receptor binding studies indicate preferential signaling agonism for CB1/CB2 and impacts the PPAR signaling pathwayIn Vivo studies demonstrate INM-901 reduces neuroinflammation and improves...

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ('InMed' or the 'Company'), a leader in the manufacturing, development and commercialization...

InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update

Advancing two new preclinical programs in Alzheimer's and Age-Related Macular DegenerationClosed calendar year 2023 with cash position of US$9.5 million164% revenue growth in the commercial BayMedica...

InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ('InMed' or the 'Company'), a leader in the manufacturing, development and...

InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ('InMed' or the 'Company'), a leader in the manufacturing, development and...

InMed Pharmaceuticals Provides Business Update and Milestones for 2024

Advancing INM-901 as a multimodal treatment option for Alzheimer's DiseaseAdvancing INM-089 in the treatment of Age-related Macular DegenerationActively seeking partnerships to advance INM-755 in...

InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. It operates through the InMed Pharma and BayMedica Commercial segments. The InMed Pharma segment focuses on research and development. The BayMedica Commercial segment refers to manufacturing technologies to produce and commercialize bulk cannabinoids for sale as ingredients in the health and wellness industry. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

InMed Pharmaceuticals Inc

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

INM
InMed Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INM News

INMInMed Pharmaceuticals Inc